A phase I trial of B7-transfected or parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401.
Hum Gene Ther
; 6(1): 87-106, 1995 Jan.
Article
en En
| MEDLINE
| ID: mdl-7703289
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Terapia Genética
/
Antígeno HLA-A1
/
Antígeno HLA-A2
/
Inmunidad Celular
/
Melanoma
/
Antígenos de Neoplasias
Tipo de estudio:
Guideline
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Hum Gene Ther
Asunto de la revista:
GENETICA MEDICA
/
TERAPEUTICA
Año:
1995
Tipo del documento:
Article